Walgreens may sell $2B pharmacy automation business

Retail pharmacy giant Walgreens is reportedly considering selling its pharmacy automation business, valued at $2 billion.

The news was first reported by Bloomberg, which cited people familiar with the matter. Walgreens is reportedly working with its advisors to start a sales process “in the next month or so,” Bloomberg reported. It is likely rival healthcare companies will be interested in acquiring the business as well as private equity firms. However, Walgreens could still opt to keep the business.

The move comes as Walgreens is shoring up its business amid a period of big transactions in the healthcare space. VillageMD, Walgreens’ affiliate, is in the middle of acquiring Summit Health-City MD. That deal, valued at nearly $10 billion, was announced last year.

Walgreens’ pharmacy automation business, iA, helps other pharmacies fill prescriptions. The retail pharmacy chain acquired a majority stake in the company in March 2021 for $451 million in cash.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.